Resonant Medical Inc. Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing
MONTREAL, April 30 /PRNewswire/ -- Resonant Medical, an innovator in 3D ultrasound image-guided adaptive radiotherapy products, today announced the appointment of Stephen Whisenhunt to the position of Vice President of Global Sales and Marketing. Whisenhunt will lead the Company's growing global sales team and manage partnerships with distributors.
Whisenhunt brings more than 18 years of radiation oncology industry experience to the Company. Prior to joining Resonant Medical, Whisenhunt served as Vice President of International Sales at Xoft, Inc., as well as Vice President of Computed Tomography at Phillips Medical. Prior to that, Whisenhunt held the position of Vice President and General Manager of Oncology Business at Picker Medical Systems and spent four years as the Director of Oncology Marketing for GE Medical Systems. Stephen is a member of The New York Academy of Sciences and holds degrees from La Salle University and Frederick Taylor University.
"Stephen's experience in the radiation oncology market and proven track record of success will be a great asset to Resonant Medical as we continue to grow our United States customer base," said Tony Falco, president and founder of Resonant Medical. "Stephen will play a pivotal role in expanding our market presence, meeting the market's demand for the Clarity System and managing our relationships with our distributors. We are pleased to welcome him to the executive team and look forward to seeing the benefits of his leadership and proven sales execution abilities."
"Resonant's technology provides a solution for a clearly unmet need in breast cancer treatment--addressing the issue of tumor movement for breast and prostate cancer patients in a way that has never been done before," said Whisenhunt. "It is exciting to be part of a growing organization producing state-of-the-art technology to help so many patients in need. I look forward to using my knowledge and experience in this industry to help foster the growth of the company, bringing this technology to patients undergoing radiation therapy."
Recently, Resonant Medical also entered into a partnership with Radiation Oncology Systems to distribute the Clarity System in the southwest region of the United States. Radiation Oncology Systems is a comprehensive provider of radiation therapy and diagnostic imaging equipment and services.
About Resonant Medical
Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products. Originally developed at McGill University Health Center, Resonant's technologies are available in more than 50 cancer centers in the U.S., Canada and Europe, helping cancer centers make significant improvements in radiation therapy planning, verification and delivery -- advancing patient care. Resonant can be found on the Web at www.resonantmedical.com
CONTACT: Wendy Ryan or Jasmine Fielding, both of Schwartz Communications
for Resonant Medical, +1-781-684-0770, Resonant@schwartz-pr.com
Web site: http://www.resonantmedical.com/